|
Genital Warts, Uganda HIV STD TESTING TREATMENT™ Notice: This is a medical information portal. This is not a clinic website. |
Genital Warts, Uganda | HIV STD TESTING TREATMENT™
SummaryGenital Warts, Uganda | HIV STD TESTING TREATMENT™ @beautyuganda_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) symptoms in men/women, screening/diagnosis, testing/check, treatment clinic, Uganda - Private and confidential service. Definitions, references, and latest news.
Description
Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
| SHIM CLINIC 168 Bedok South Avenue 3 #01-473 Singapore 460168  Tel: (+65) 6446 7446 Fax: (+65) 6449 7446 24hr Answering Tel: (+65) 6333 5550 Web: Genital Warts, Uganda | Opening Hours Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm Saturday & Sunday: 7 pm to 11 pm Public Holidays: Closed Last registration: half hour before closing time. Walk-in clinic. Appointments not required. Bring NRIC, Work Pass or Passport for registration. |
Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.
| Timeline | Event / Available resources | ||
|---|---|---|---|
| HIV | STD | Pregnancy | |
| Before exposure | |||
| Contraception (females only) | |||
| HIV PrEP (pre-exposure prophylaxis) | STD vaccine: - Hepatitis vaccine - HPV vaccine | ||
| STD / HIV exposure | No condom / Condom broke / Condom slip | ||
| 0-72 hours | HIV prevention HIV PEP (post-exposure prophylaxis) treatment - Stop HIV infection after exposure. | STD testing If STD symptoms appear, then do STD treatment. - Males: Do not urinate for at least 4 hours before arriving. - Females: testing is more accurate when you are not menstruating. | Emergency contraception (females only) |
| 2 weeks | HIV DNA PCR test | ||
| 1 month | 20 minute Alere™ Determine™ Combo HIV rapid test: - Fingerprick blood sampling. | ||
| 3 months | 20 minute OraQuick® HIV rapid test: - Oral saliva or - Fingerprick blood sampling. | Full & comprehensive STD testing - Males: Do not urinate for at least 4 hours before arriving. - Females: testing is more accurate when you are not menstruating. | |
References
Latest News
Blood test one day may detect oral cancer from oral sex
Tue, 18 Jun 2013 01:52:46 +0100 | Health News - UPI.com
BETHESDA, Md., June 17 (UPI) -- A test may one day detect human papillomavirus to identify those of increased risk of HPV-related oral cancer as a result of oral sex, U.S. researchers say. (Source: Health News - UPI.com)
Non-detection of Epstein-Barr virus and human papillomavirus in a region of high gastric cancer risk indicates a lack of a role for these viruses in gastric carcinomas
Mon, 17 Jun 2013 06:17:32 +0100 | Genetics and Molecular Biology
Gastric mucosa tissue was collected from patients with gastroduodenal diseases in a region of norrteastern China showing a high risk of gastric cancer incidence. The presence of EBV and HPV were assayed to investigate the relationship between gastric carcinomas and virus infection. Neither EBV nor HPV DNA was detected in tissue from the patients. The role of EBV and HPV in gastric cancer is not well understood and still needs to be clarified. (Source: Genetics and Molecular Biology)
NIH scientists find promising biomarker for predicting HPV-related oropharynx cancer
Mon, 17 Jun 2013 04:00:00 +0100 | EurekAlert! - Medicine and Health
(NIH/National Cancer Institute) Researchers have found that antibodies against the human papillomavirus may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils. (Source: EurekAlert! - Medicine and Health)
Circulating CD4‐positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancer
Fri, 14 Jun 2013 04:00:00 +0100 | Head and Neck
Conclusion. These findings demonstrate the potential importance of the immune system in chemotherapy response and clinical outcome. Differences in findings between patients with advanced laryngeal and oropharyngeal cancer may reflect different cellular immunity function in the patients with human papillomavirus (HPV)‐16+ oropharyngeal cancer. © 2013 Wiley Periodicals, Inc. Head Neck, 2013 (Source: Head and Neck)
Use of the HPV MLPA assay in cervical cytology for the prediction of high grade lesions
Thu, 13 Jun 2013 04:00:00 +0100 | Journal of Medical Virology
This study demonstrates that the HPV MLPA assay can reliably detect HPV 16/18, viral load, and viral integration in cytological samples. Also, high‐risk classification correlated well with the presence of high‐grade dysplasia. However, for the implementation of the MLPA assay into clinical practice, additional HR‐HPV types need to be included to increase the sensitivity of the assay, and thereby increase its negative predictive value. J. Med. Virol. 85:1386–1393, 2013. © 2013 Wiley Periodicals, Inc. (Source: Journal of Medical Virology)
Characterization of cytomegalovirus and epstein‐barr virus infection in cervical lesions in Portugal
Thu, 13 Jun 2013 04:00:00 +0100 | Journal of Medical Virology
This study revealed an overall prevalence of 4.5% for CMV and 10.1% for EBV. Age‐stratified analysis revealed that CMV infection was present in individuals <30 and >60 years old, while EBV infection was present in all age groups. CMV was detected in 9.5% of low‐grade lesions and in 22.2% of in situ/invasive carcinomas, while EBV infection was found in all different types of lesions. In addition, data revealed that CMV infection was associated with an increased risk of in situ/invasive carcinoma development (OR = 1.28; P = 0.035). The study reveals a low prevalence for both viruses; nevertheless, these results are important for knowledge on the shedding of EBV and CMV in cervical samples. J. Med. Virol. 85:1409–1413, 2013. © 2013 Wiley Periodicals, Inc. (Source: Journal...
Juvenile respiratory papillomatosis: Risk factors for severity
Thu, 13 Jun 2013 04:00:00 +0100 | Journal of Medical Virology
Abstract
Development of Culturally Tailored Educational Brochures on HPV and Pap Tests for American Indian Women
Thu, 13 Jun 2013 04:00:00 +0100 | Journal of Transcultural Nursing
Conclusions: A participatory process successfully engaged nursing staff and patients in creating culturally appropriate brochures for clinic use. Implications for Practice: This article provides specific steps for creating culturally tailored patient education materials. (Source: Journal of Transcultural Nursing)
High‐grade squamous intraepithelial lesion in women aged
Thu, 13 Jun 2013 04:00:00 +0100 | Cancer Cytopathology
CONCLUSIONSThe prevalence pattern of HSIL suggestive of CIN 2 resembled the pattern observed in LSIL and was more prevalent than HSIL suggestive of CIN 3 in younger women. The impact of screening was less evident when HSIL was suggestive of CIN 2. A conservative approach for younger women who have HSIL is important for management guidance. Cancer (Cancer Cytopathol) 2013. © 2013 American Cancer Society. (Source: Cancer Cytopathology)
Answering human papillomavirus vaccine concerns; a matter of science and time
Wed, 12 Jun 2013 04:00:00 +0100 | Infectious Agents and Cancer
Since the introduction of the HPV vaccine, questions have been asked about its efficacy in preventing cancer linked with HPV. Concerns about the HPV vaccine safety profile have also been raised. This paper highlights the rapidly growing body of evidence (including clinical trials and post-marketing surveillance) illustrating both the safety of the HPV vaccine, through a detailed investigation of reported adverse events, and its efficacy in reducing both HPV infections rates and the resulting drop in cervical lesions, which have been demonstrated to be good predictors of cervical cancer risk (Source: Infectious Agents and Cancer)
| Singapore Web Design by Zeus Micro | Copyrighted Material: Not for Reproduction or Distribution |